This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Check our privacy policy here.
Funding
Oncostellae was founded in 2013.
In 2014, Oncostellae’s R&D projects were initiated using private funds provided by the founders and a subvention granted by the Galician Agency for Innovation (GAIN) and the European Union (ERDF) for the development of the project Oncogalfarma within the framework Conecta Peme 2014/15.
In 2015 Inveready entered the company as a financial partner.
In 2016 Oncostellae received a loan (ENISA) from the Ministry of Industry, Commerce and Tourism. Further funding was provided for the project Neogalfarm (Conecta Pyme 2016/17) to a consortium formed by Oncostellae, Galchimia, Nanogap, AMSLAB.
In 2017 public and private investors including Xesgalicia, Unirisco and FiTalent/Everis joined the company as financial partners.
In 2018 Oncostellae received public funding from the Ministry of Science & Innovation within the program Retos-Colaboración 2017. Further funding was provided for the project IO4COLON within the framework of Conecta Pyme 2018-20 granted by the Galician Agency for Innovation (GAIN) and the European Union (ERDF).
In 2019 Oncostellae completed an internal financing round.
R&D Projects
Corporate Projects
Other Support Resources
Funding
Enisa
Oncostellae is supported by ENISA (a public institution that finances new and innovative program) and co-financied by the European Regional Development Fund: «A way to build Europe«.
